Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$149.63M
Total Bought:
$32.01M
Total Sold:
$27.17M
Net Transaction:
+$4.84M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Rhythm Pharmaceuticals, Inc.(RYTM)730,000825,500+95,500$33.56M$35.77M23.91%+$2.21M
argenx SEADR(ARGX)70,00082,000+12,000$26.63M$32.29M21.58%+$5.65M
Cytokinetics, Incorporated(CYTK)230,000190,000-40,000$19.20M$13.32M8.90%-$5.88M
Avadel Pharmaceuticals PlcADR325,000701,387+376,387$4.59M$11.85M7.92%+$7.26M
Axsome Therapeutics, Inc.(AXSM)155,346132,437-22,909$12.36M$10.57M7.06%-$1.80M
Mirum Pharmaceuticals, Inc.(MIRM)233,659362,193+128,534$6.90M$9.10M6.08%+$2.20M
Protagonist Therapeutics Inc266,856280,301+13,445$6.12M$8.11M5.42%+$1.99M
Corcept Therapeutics Incorporated(CORT)0273,776+273,776$0$6.90M4.61%+$6.90M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)880,000618,528-261,472$10.07M$5.39M3.60%-$4.68M
Phathom Pharmaceuticals, Inc.(PHAT)359,446445,161+85,715$3.28M$4.73M3.16%+$1.45M
Atyr Pharma Inc1,503,5541,446,477-57,077$2.12M$2.82M1.89%+$700.6K
Verastem, Inc.(VSTM)0168,739+168,739$0$1.99M1.33%+$1.99M
GH Research PLC(GHRS)293,945185,653-108,292$1.70M$1.98M1.32%+$274.2K
Trevi Therapeutics, Inc.(TRVI)1,292,316506,082-786,234$1.73M$1.75M1.17%+$14.3K
Applied Therapeutics Inc0220,000+220,000$0$1.50M1.00%+$1.50M
Allakos Inc444,804767,964+323,160$1.21M$967.6K0.65%-$246.7K
Atara Biotherapeutics Inc0892,853+892,853$0$619.6K0.41%+$619.6K
Aclaris Therapeutics, Inc.(ACRS)453,6140-453,614$476.3K$0—-$476.3K
Disc Medicine, Inc.(IRON)10,0000-10,000$577.6K$0—-$577.6K
Edgewise Therapeutics, Inc.(EWTX)33,0000-33,000$361.0K$0—-$361.0K
Springworks Therapeutics Inc340,0000-340,000$12.41M$0—-$12.41M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q1 2024 | TickerTrail